Metz, M., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Kangas, M., . . . Maurer, M. (2017). Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin. Theranostics.
Dyfyniad Arddull ChicagoMetz, Martin, et al. "Clinical Efficacy of Omalizumab in Chronic Spontaneous Urticaria Is Associated With a Reduction of FcεRI-positive Cells in the Skin." Theranostics 2017.
Dyfyniad MLAMetz, Martin, et al. "Clinical Efficacy of Omalizumab in Chronic Spontaneous Urticaria Is Associated With a Reduction of FcεRI-positive Cells in the Skin." Theranostics 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.